Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocean Biomedical Inc
(NQ:
OCEA
)
1.070
-0.020 (-1.83%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ocean Biomedical Inc
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
February 26, 2024
Via
AB Newswire
Ocean Biomedical Inc. (NASDAQ: OCEA) Shares Promising Results on World Lung Cancer Day
August 01, 2023
Via
Investor Brand Network
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
From
FN Media Group LLC
Via
GlobeNewswire
BioMedNewsBreaks – Ocean Biomedical Inc. (NASDAQ: OCEA) Shares Promising Results on World Lung Cancer Day
August 01, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Share Price Target Increased in FRC Report, Receives US Patent for Cancer Immunotherapy Treatment
June 28, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
BioMedNewsBreaks — Ocean Biomedical Inc. (NASDAQ: OCEA) Cofounder Issued Key US Patent for Bispecific Cancer Immunotherapy Treatment
June 27, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Ocean Biomedical (NASDAQ: OCEA) Receives U.S. Patent Approval Notice for New Malaria Treatment
April 13, 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA) is engaged as a biopharmaceutical company, which is focused on the development and commercialization of
Via
Spotlight Growth
Topics
Intellectual Property
Exposures
Intellectual Property
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028
May 26, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END
Via
FinancialNewsMedia
Ocean Biomedical (NASDAQ: OCEA) Skyrockets 324% After Announcing Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Shown to Kill Glioblastoma & Melanoma Cancer Cells
February 23, 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a Rhode Island-based biopharmaceutical company, which is focused on the development and commercialization of
Via
Spotlight Growth
BioMedNewsBreaks – Aesther Healthcare Acquisition Corp. and Ocean Biomedical Inc. (NASDAQ: OCEA) Announce Approved Business Combination
February 16, 2023
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.